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While reducing the amount of virus 
circulating in and between individuals 
might be a key strategy to limit SARS-
CoV-2 spread, on the basis of the 
existing evidence (appendix), it seems 
unlikely that the inoculum size has 
any major role in determining disease 
severity of secondary cases.
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viral load might affect 
transmission but not 
disease severity in 
secondary cases
We read with interest the Personal 
View by Matthew A Spinelli and 
colleagues.1 We agree with the 
authors on the evident advantage 
provided by non-pharmaceutical 
interventions (facial masking, social 
distancing, and improved ventilation) 
in lowering SARS-CoV-2 inoculum, 
thereby reducing viral transmission. 
Nevertheless, we call for caution 
before asserting that such measures 
could make a substantial difference in 
reducing COVID-19 severity.
Animal models examining a 
potential dose–response relationship 
reported conflicting results, and 
experimental inoculation might 
inaccurately mimic real-life infection 
dynamics,2 including inoculum doses. 
Two studies are cited to support 
Spinelli and colleagues’ hypothesis.3,4 
Bielecki and colleagues observed 
no symptomatic SARS-CoV-2 
infections in a military company 
where protective measures were 
rigorously implemented, whereas 47% 
of all infections were symptomatic 
in an identical company where such 
measures were less strict.3 This finding 
is hardly applicable to the general 
population as the study was in young 
(median age 20 years), healthy 
individuals.3 Bias due to sampling 
and testing based on self-reported 
symptoms could not be ruled out, 
non-airborne routes of transmission 
could have prevailed, and the primary 
study aim was not to assess the 
potential relationship of viral inoculum 
with disease severity.
The second study cited by Spinelli 
and colleagues investigated the 
relationship of viral load with several 
characteristics of index and secondary 
cases, as well as with transmission 
risk in outpatient clusters.4 The study 
did not observe any dose–response 
relationship between index viral load 
and the probability of symptomatic 
infections in contacts, nor did it 
identify any correlation between 
the index cases’ viral amount and 
COVID-19 incubation length or first 
viral load in incident secondary cases,4 
by contrast with what was stated by 
Spinelli and colleagues.1
We recently observed no difference 
in occurrence of symptomatic 
infections, hospitalisation, and 
death in household secondary cases 
when stratified by viral load of 
their linked index source cases.5 As 
previously detailed,5 it seems that host 
permissiveness (eg, age, sex, receptor 
density, genetic and epigenetic 
factors, host immunological features, 
comorbidities, comedications) is the 
key factor in allowing subsequent 
viral replication and triggering 
of inflammatory and immune-
pathological processes rather than 
viral amount at exposure. 
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